Dr. Falk Pharma GmbH

Allemagne


Commandez votre montre hebdomadaire Dr. Falk Pharma GmbH
Quantité totale PI 175
Quantité totale incluant filiales 191 (+ 16 pour les filiales)
Rang # Quantité totale PI 7 578
Note d'activité PI 2,9/5.0    91
Rang # Activité PI 7 495
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

28 4
11 9
21 56
46
 
Dernier brevet 2025 - Anti-cd30l antibodies, formulati...
Premier brevet 1994 - Budesonide pellets with a contro...
Dernière marque 2025 - UZUNCA
Première marque 1973 - HEPATOFALK

Filiales

1 subsidiaries with IP (8 patents, 8 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical preparations, namely in the fields of gastroenterology and hepatology.
P/S Pharmaceutical preparations.
P/S Pharmaceutical preparations, namely in the fields of gastroenterology and hepatology
P/S Medicinal preparations and substances; Pharmaceuticals and natural remedies; Pharmaceutical drugs...
Invention Method for personalized therapy of celiac disease. The present invention relates to a method for ...
Invention Orally applicable suspension for the treatment of eosinophilic esophagitis in children. Disclosed...
2024 P/S Pharmaceutical preparations for the treatment of the intestinal tract including the esophagus
P/S Pharmaceutical preparations for the treatment of the intestinal tract and the liver
2023 P/S Pharmaceutical preparations for the treatment of metabolic diseases and diseases of the digestive...
Invention Anti-cd30l antibodies, formulations therefor, and uses thereof. Described herein are anti-CD30L ...
Invention Anti-cd30l antibodies, formulations therefor, and uses thereof. Described herein are anti-CD30L a...
Invention Pharmaceutical formulation for the treatment of inflammatory changes to the rectum. Disclosed is ...
2022 Invention Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of inte...
Invention Anti-cd30l antibodies and uses thereof. Described herein are anti-CD30L antibodies and pharmaceut...
Invention Pharmaceutical composition for the oral administration of poorly soluble drugs comprising an amor...
Invention 3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) propanoic acid derivatives as kmo inhibitors. A compoun...
Invention Orodispersible effervescent tablet comprising budesonide for use in the treatment of eosinophilic...
Invention Anti-cd30l antibodies and uses thereof. Described herein are anti-CD30L antibodies and pharmaceu...
Invention Enema for rectal application. Provided is an enema for rectal application containing budesonide a...
2021 P/S Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune disease...
P/S Pharmaceutical preparations, namely for the domains of gastroenterology and hepatology.
P/S Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseas...
P/S Pharmaceuticals.
Invention Systemic formulation of a pyridinone derivate for tg2-related diseases. The present invention re...
Invention Systemic formulation of a pyridinone derivate for coeliac disease. The present invention relates...
Invention Systemic formulation of a pyridinone derivate for tg2-related diseases. The present invention rel...
Invention Systemic formulation of a pyridinone derivate for coeliac disease. The present invention relates ...
2020 Invention Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagu...
2019 Invention Pellets having a multi-layer structure for delayed release of the active substance in the distal ...
Invention Method of treating pancreatitis using 1,4-benzoxazine derivatives. The present invention relates ...
2018 Invention Use of nor-ursodeoxycholic acid for reducing liver fat. The present invention relates to the use ...
Invention 3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhib...
2017 P/S Intestinal disorder medicine for the treatment of ulcerative colitis.
P/S Pharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract
2016 Invention Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size. ...
Invention Optimized high-dose mesalazine-containing tablet. The present invention relates to an oral enteri...
Invention Optimised high-dose mesalazine-containing tablet. The invention relates to an oral gastric-juice ...
Invention Pharmaceutical formulation for the treatment of inflammatory changes to the rectum. The invention...
Invention 3-(6-chloro-3-oxo-3,4-dihydro-(2h)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use ...
2015 Invention Enema for rectal application. Provided is an enema for rectal application containing budesonide ...
2014 Invention Pellet formulation for the treatment of the intestinal tract. An orally administrable pharmaceut...
Invention Method of treating ulcerative colitis. Provided herein are methods of treating and inducing ulce...
Invention Method for treating ulcerative colitis. Provided herein are methods of treating and inducing ulc...
Invention Methods of treating ulcerative colitis. Provided herein are methods of treating and inducing ulc...
2013 Invention Pharmaceutical formulation for treating the upper digestive tract. The invention relates to an e...
Invention Compositions and methods for treatment of irritable bowel syndrome with 5-aminosalicylate. Embodi...